- Home
- COSM vs CVKD Comparison
COSM vs CVKD Comparison
Compare COSM & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- CVKD
- Stock Information
- Founded
- COSM 2009
- CVKD 2022
- Country
- COSM United States
- CVKD United States
- Employees
- COSM N/A
- CVKD N/A
- Industry
- COSM Other Pharmaceuticals
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- COSM Health Care
- CVKD Health Care
- Exchange
- COSM Nasdaq
- CVKD Nasdaq
- Market Cap
- COSM 32.3M
- CVKD 27.0M
- IPO Year
- COSM 2013
- CVKD 2023
- Fundamental
- Price
- COSM $0.75
- CVKD $11.25
- Analyst Decision
- COSM
- CVKD Strong Buy
- Analyst Count
- COSM 0
- CVKD 1
- Target Price
- COSM N/A
- CVKD $32.00
- AVG Volume (30 Days)
- COSM 462.3K
- CVKD 21.9K
- Earning Date
- COSM 11-14-2025
- CVKD 11-10-2025
- Dividend Yield
- COSM N/A
- CVKD N/A
- EPS Growth
- COSM N/A
- CVKD N/A
- EPS
- COSM N/A
- CVKD N/A
- Revenue
- COSM $55,093,442.00
- CVKD N/A
- Revenue This Year
- COSM $28.14
- CVKD N/A
- Revenue Next Year
- COSM N/A
- CVKD N/A
- P/E Ratio
- COSM N/A
- CVKD N/A
- Revenue Growth
- COSM N/A
- CVKD N/A
- 52 Week Low
- COSM $0.28
- CVKD $8.74
- 52 Week High
- COSM $1.32
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- COSM 37.07
- CVKD 39.39
- Support Level
- COSM $0.70
- CVKD $11.51
- Resistance Level
- COSM $0.77
- CVKD $13.01
- Average True Range (ATR)
- COSM 0.08
- CVKD 0.82
- MACD
- COSM -0.01
- CVKD -0.14
- Stochastic Oscillator
- COSM 21.30
- CVKD 21.29
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.